Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 4778 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

Management of statin intolerance

Raju Soma B, Varghese Kiron, Madhu K

Year : 2013| Volume: 17| Issue : 6 | Page no: 977-982

   This article has been cited by
 
1 Future perspectives of the pharmacological management of diabetic dyslipidemia
Angelo Maria Patti,Rosaria Vincenza Giglio,Nikolaos Papanas,Manfredi Rizzo,Ali A. Rizvi
Expert Review of Clinical Pharmacology. 2019; 12(2): 129
[Pubmed]  [Google Scholar] [DOI]
2 Statins: Complex outcomes but increasingly helpful treatment options for patients
Niloufar Mohammadkhani,Sedigheh Gharbi,Huda Fatima,Avishan Farzaneh,Golnoosh Mahjoob,Afsaneh Hoseinsalari,Eberhard Korsching
European Journal of Pharmacology. 2019; : 172704
[Pubmed]  [Google Scholar] [DOI]
3 Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance
Jordon C. Irwin,Andrew S. Fenning,Rebecca K. Vella
Translational Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
Richard Myles Turner,Munir Pirmohamed
Journal of Clinical Medicine. 2019; 9(1): 22
[Pubmed]  [Google Scholar] [DOI]
5 Management of Statin Intolerance in 2018: Still More Questions Than Answers
Peter P. Toth,Angelo Maria Patti,Rosaria Vincenza Giglio,Dragana Nikolic,Giuseppa Castellino,Manfredi Rizzo,Maciej Banach
American Journal of Cardiovascular Drugs. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Statin Intolerance: an Overview of the Current Status and Possible Treatment Options
Sunghwan Suh,Chang Hee Jung,Soon-Jun Hong,Jung-Sun Kim,Sung Hee Choi
Journal of Lipid and Atherosclerosis. 2018; 7(2): 77
[Pubmed]  [Google Scholar] [DOI]
7 Satisfaction With Statin Treatment Among Adult Coronary Artery Disease Patients: An Experience From a Resource-Constrained Setting
Rubina Mulchandani,Tanica Lyngdoh,Praloy Chakraborty,Ashish Kumar Kakkar
Heart, Lung and Circulation. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy
Eliot A. Brinton
Clinical Cardiology. 2018; 41(6): 710
[Pubmed]  [Google Scholar] [DOI]
9 Statin intolerance – a question of definition
Engi Abdel-Hady Algharably,Iris Filler,Stephanie Rosenfeld,Katja Grabowski,Reinhold Kreutz
Expert Opinion on Drug Safety. 2017; 16(1): 55
[Pubmed]  [Google Scholar] [DOI]
10 The reno-protective effects of atorvastatin in crush syndrome and rhabdomyolysis:is there a dilemma?
Demet ACAR,Mustafa GÜLPEMBE,Can Gökay YILDIZ,Emine Nur ÖZDAMAR,Kerem AÇIKGÖZ,Ahmet ÇAGLAR,Basar CANDER
TURKISH JOURNAL OF MEDICAL SCIENCES. 2017; 47: 1920
[Pubmed]  [Google Scholar] [DOI]
11 Statin related adverse effects and patient education: a study from resource limited settings
Rubina Mulchandani,Tanica Lyngdoh,Praloy Chakraborty,Ashish Kumar Kakkar
Acta Cardiologica. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
12 Expert opinion: the therapeutic challenges faced by statin intolerance
Jaideep Patel,Seth S Martin,Maciej Banach
Expert Opinion on Pharmacotherapy. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
13 Atorvastatin and metformin administration modulates experimental Trichinella spiralis infection
Ahmad A. Othman,Dina M. Abou Rayia,Dalia S. Ashour,Eman M. Saied,Doaa H. Zineldeen,Ahmad A. El-Ebiary
Parasitology International. 2016; 65(2): 105
[Pubmed]  [Google Scholar] [DOI]
14 Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach,Manfredi Rizzo,Peter P Toth,Michel Farnier,Michael H Davidson,Khalid Al-Rasadi,Wilbert S Aronow,Vasilis Athyros,Dragan M Djuric,Marat V Ezhov,Robert S Greenfield,G Kees Hovingh,Karam Kostner,Corina Serban,Daniel Lighezan,Zlatko Fras,Patrick M Moriarty,Paul Muntner,Assen Goudev,Richard Ceska,Stephen J Nicholls,Marlena Broncel,Dragana Nikolic,Daniel Pella,Raman Puri,Jacek Rysz,Nathan D Wong,Laszlo Bajnok,Steven R Jones,Kausik K Ray,Dimitri P Mikhailidis
Expert Opinion on Drug Safety. 2015; 14(6): 935
[Pubmed]  [Google Scholar] [DOI]
15 Statin Alternatives: A Review of Over-the-Counter Lipid-Lowering Supplements
Joseph V. Danavi,Shermeen B. Memon,Binh An P. Phan
Alternative and Complementary Therapies. 2015; 21(5): 198
[Pubmed]  [Google Scholar] [DOI]
16 Management of dyslipidaemia in statin-intolerant patients in light of AHA and NPA guidelines of 2013–2014
Soumya Patnaik,Amar Narayan Patnaik
Journal of Indian College of Cardiology. 2015; 5(2): 119
[Pubmed]  [Google Scholar] [DOI]
17 Statin-induced rhabdomyolysis mimicking polymyositis on18F-FDG PET imaging
H. Yildiz,V. Roelants,P. Hainaut
Acta Clinica Belgica. 2015; 70(2): 151
[Pubmed]  [Google Scholar] [DOI]

 

Read this article